A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease (Q39218023)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease |
scientific article |
Statements
1 reference
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease (English)
1 reference
Hartmut Döhner
1 reference
Walter Fiedler
1 reference
Hubert Serve
1 reference
Michael Schwittay
1 reference
Oliver G Ottmann
1 reference
Anne-Marie O'Farrell
1 reference
Carlo L Bello
1 reference
Randy Allred
1 reference
William C Manning
1 reference
Julie M Cherrington
1 reference
Sharianne G Louie
1 reference
Weiru Hong
1 reference
Nicoletta M Brega
1 reference
Giorgio Massimini
1 reference
Paul Scigalla
1 reference
Wolfgang E Berdel
1 reference
Dieter K Hossfeld
1 reference
30 September 2004
1 reference
Identifiers
1 reference